Retrophin to Report Second Quarter 2020 Financial Results
16 Julio 2020 - 3:30PM
Retrophin, Inc. (NASDAQ: RTRX) today announced it will report
second quarter 2020 financial results on Thursday, July 30, 2020
after the close of the U.S. financial markets. The Company will
host a conference call and webcast to discuss the financial results
and provide a general business update at 4:30 p.m. ET.
Conference Call Information
Date: |
Thursday, July 30, 2020 |
Time: |
4:30 p.m.
ET |
Dial-in
numbers: |
+1 (855)
219-9219 (U.S.) or +1 (315) 625-6891 (International) |
Confirmation code: |
6024625 |
Live
webcast: |
Retrophin.com in the “Events & Presentations” section of
the “Investors” page |
A replay of the call will be available from 7:30
p.m. ET, July 30, 2020 to 7:30 p.m. ET, August 6, 2020. The replay
number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406
(International), confirmation code 6024625.
About Retrophin
Retrophin is a biopharmaceutical company
specializing in identifying, developing and delivering
life-changing therapies to people living with rare disease. The
Company’s approach centers on its pipeline featuring sparsentan, a
product candidate in late-stage development for focal segmental
glomerulosclerosis (FSGS) and IgA nephropathy (IgAN), rare
disorders characterized by progressive scarring of the kidney often
leading to end-stage renal disease. Research in additional rare
diseases is also underway, including partnerships with leaders in
patient advocacy and government research to identify potential
therapeutics for NGLY1 deficiency and Alagille syndrome, conditions
with no approved treatment options. Retrophin’s R&D efforts are
supported by revenues from the Company’s commercial products
Chenodal®, Cholbam®, Thiola® and Thiola EC®.
Retrophin.com
Contact:Chris Cline,
CFA
Senior
Vice President, Investor Relations & Corporate
Communications888-969-7879
IR@retrophin.com
Retrophin (NASDAQ:RTRX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Retrophin (NASDAQ:RTRX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Retrophin Inc (NASDAQ): 0 recent articles
Más de Artículos de Noticias